Daiwa Securities Group’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.05M Buy
3,657
+10
+0.3% +$2.87K ﹤0.01% 742
2025
Q1
$1.12M Sell
3,647
-634
-15% -$195K ﹤0.01% 708
2024
Q4
$1.51M Buy
4,281
+162
+4% +$57.2K 0.01% 655
2024
Q3
$1.48M Buy
4,119
+852
+26% +$305K 0.01% 652
2024
Q2
$1.04M Sell
3,267
-410
-11% -$131K 0.01% 700
2024
Q1
$845K Buy
3,677
+485
+15% +$111K ﹤0.01% 743
2023
Q4
$702K Buy
3,192
+123
+4% +$27.1K ﹤0.01% 769
2023
Q3
$693K Buy
3,069
+100
+3% +$22.6K ﹤0.01% 765
2023
Q2
$655K Sell
2,969
-14
-0.5% -$3.09K ﹤0.01% 760
2023
Q1
$668K Buy
2,983
+2,800
+1,530% +$627K ﹤0.01% 750
2022
Q4
$51K Buy
183
+14
+8% +$3.9K ﹤0.01% 1032
2022
Q3
$35K Hold
169
﹤0.01% 1074
2022
Q2
$40K Buy
169
+38
+29% +$8.99K ﹤0.01% 1089
2022
Q1
$24K Hold
131
﹤0.01% 1103
2021
Q4
$28K Sell
131
-23
-15% -$4.92K ﹤0.01% 1099
2021
Q3
$28K Buy
154
+66
+75% +$12K ﹤0.01% 1087
2021
Q2
$16K Hold
88
﹤0.01% 1023
2021
Q1
$15K Buy
88
+4
+5% +$682 ﹤0.01% 1024
2020
Q4
$13K Sell
84
-164
-66% -$25.4K ﹤0.01% 1002
2020
Q3
$25K Hold
248
﹤0.01% 968
2020
Q2
$24K Hold
248
﹤0.01% 1005
2020
Q1
$24K Hold
248
﹤0.01% 990
2019
Q4
$22K Sell
248
-30
-11% -$2.66K ﹤0.01% 997
2019
Q3
$22K Hold
278
﹤0.01% 981
2019
Q2
$22K Sell
278
-1,500
-84% -$119K ﹤0.01% 994
2019
Q1
$209K Sell
1,778
-21
-1% -$2.47K ﹤0.01% 857
2018
Q4
$196K Buy
1,799
+210
+13% +$22.9K ﹤0.01% 817
2018
Q3
$203K Hold
1,589
﹤0.01% 850
2018
Q2
$180K Hold
1,589
﹤0.01% 880
2018
Q1
$179K Buy
1,589
+239
+18% +$26.9K ﹤0.01% 857
2017
Q4
$200K Hold
1,350
﹤0.01% 842
2017
Q3
$158K Hold
1,350
﹤0.01% 845
2017
Q2
$175K Hold
1,350
﹤0.01% 827
2017
Q1
$183K Buy
1,350
+200
+17% +$27.1K ﹤0.01% 801
2016
Q4
$165K Hold
1,150
﹤0.01% 802
2016
Q3
$136K Buy
1,150
+100
+10% +$11.8K ﹤0.01% 754
2016
Q2
$111K Buy
1,050
+150
+17% +$15.9K ﹤0.01% 787
2016
Q1
$100K Sell
900
-7,000
-89% -$778K ﹤0.01% 809
2015
Q4
$1.24M Buy
7,900
+7,000
+778% +$1.1M 0.01% 325
2015
Q3
$118K Sell
900
-1,800
-67% -$236K ﹤0.01% 784
2015
Q2
$470K Buy
+2,700
New +$470K ﹤0.01% 539